CD274 and cancer: Broadly, current immunotherapeutic strategies fall into five categories: (1) immunomodulators, (2) immune-checkpoint-blocking mAbs such as PD-1/PD-L1 inhibitors, (3) therapeutic cancer vaccines, (4) adoptive-cellular therapies, and (5) oncolytic viruses.